Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer

Journal of Urology

Volumn 166, Issue 4, 2001, Pages 1275-1279

  Bernardini, S ^a,b   Fauconnet, S ^a   Chabannes, E ^a   Henry, P C ^a   Adessi, G ^a   Bittard, H ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b Service d'Urologie   (France)

Author keywords

Biological; Bladder; Bladder neoplasms; Endothelial growth factors; Prognosis; Tumor markers

Indexed keywords

BCG VACCINE; TUMOR MARKER; VASCULOTROPIN;

ACCURACY; ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD CHEMISTRY; BLOOD LEVEL; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION;

EID: 0034827699     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65752-7     Document Type: Article

References (30)

1. Molecular mediators of angiogenesis in bladder cancer
2. Different angiogenic pathways characterize superficial and invasive bladder cancer
3. Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line
4. Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence
5. The angiogenetic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers
6. The vascular endothelial growth factor family identifcation of a fourth molecular species and characterization of alternative splicing of RNA
7. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells
8. Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis and tumor progression
9. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer
10. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates
11. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma
12. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: Correlation with patient survival
13. Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancer
14. Major surgery increases serum levels of vascular endothelial growth factor only temporarily
15. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma
16. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease
17. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: Correlation with clinicopathological factors and tumors markers
18. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma
19. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer
20. Serum concentrations of VEGF, b-FGF in renal cell, prostate and urinary bladder carcinomas
21. The biology of vascular endothelial growth factor
22. Release of the angiogenetic cytokine vascular endothelial growth factor from platelets: Significance for VEGF measurements and cancer biology
23. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: Which is the optimal specimen?
24. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging?
25. Eukaryotic initiation factor- 4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression
26. Expression of vascular endothelial growth factor gene and its receptor (flt-1) gene in urinary bladder cancer
27. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder
28. Serum vascular endothelial growth factor is often elevated in disseminated cancer
29. Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer
30. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy